Dexmedetomidine and dezocine targets (NR1H3 and ADRB1) are potential prognostic biomarkers for breast cancer.

ABSTRACT:

SUBMITTER: Zhang S 

PROVIDER: S-EPMC12753599 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature